// App-Quantinova.ai

17102 : Lower Rate of Device-Related Thrombosis in Watchman Patients Undergoing a Genotype-Tailored Antithrombotic Strategy

Researchers

Presenter

  • Domenico G Della Rocca

Principal Investigators

  • Rodney Horton

  • Carola Gianni

  • Luigi Di Biase

  • CHINTAN G TRIVEDI

  • Sanghamitra Mohanty

  • Nicola Tarantino

  • Mohamed Bassiouny

  • Amin Al-ahmad

  • David Burkhardt

  • G Gallinghouse

  • Javier Sanchez

  • Andrea Natale

Medical Centers

  • TEXAS CARDIAC ARRHYTHMIA INSTITUTE, Austin, TX

  • TX, Austin, TX

  • EP, Texas Cardiac Arrhythmia Institute, Austin, TX

  • 400 Central Park West Apt 9G, New York, NY

  • MONTEFIORE MEDICAL CENTER, BRONX, NY

  • Texas Cardiac Arrhythmia, Austin, TX

  • Texas Cardiac Arrhythmia, Dallas, TX

  • TEXAS CARDIAC ARRHYTHMIA INSTITUTE, Austin, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Cytochrome P450 2C19

Drug/Treatment

  • Clopidogrel bisulfate

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved